{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T20:04:36Z","timestamp":1789416276681,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.coph.2025.102548","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T02:39:03Z","timestamp":1750300743000},"page":"102548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Transdermal delivery of antibacterial peptides in the management of methicillin-resistant Staphylococcus aureus"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4174-1342","authenticated-orcid":false,"given":"Shivraj Sangappa","family":"Shivpuje","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3993-8851","authenticated-orcid":false,"given":"Durgacharan A.","family":"Bhagwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7022-9513","authenticated-orcid":false,"given":"Pankaj Ashok","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4512-2489","authenticated-orcid":false,"given":"Kimaya P.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1995-136X","authenticated-orcid":false,"given":"Suraj N.","family":"Mali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2025.102548_bib1","series-title":"Ten threats to global health in 2019","year":"2019"},{"key":"10.1016\/j.coph.2025.102548_bib2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2025.102548_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/sumbio\/qvae007","article-title":"Prevalence, characterization, and implications of methicillin-resistant Staphylococcus aureus (MRSA) in ready-to-eat foods from Delta, Nigeria: a concern for consumer safety","volume":"1","author":"Beshiru","year":"2024","journal-title":"Sustain Microbiol"},{"key":"10.1016\/j.coph.2025.102548_bib4","article-title":"Control and management of multidrug resistant Acinetobacter baumannii: a review of the evidence and proposal of novel approaches","volume":"2","author":"Weinberg","year":"2020","journal-title":"Infect Prev Pract"},{"key":"10.1016\/j.coph.2025.102548_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jare.2019.10.005","article-title":"Vancomycin resistant Staphylococcus aureus infections: a review of case updating and clinical features","volume":"21","author":"Cong","year":"2020","journal-title":"J Adv Res"},{"key":"10.1016\/j.coph.2025.102548_bib6","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1073\/pnas.122108599","article-title":"The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)","volume":"99","author":"Enright","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.coph.2025.102548_sref7","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2023.100954","article-title":"Antimicrobial peptides for combating drug-resistant bacterial infections","volume":"68","author":"Xuan","year":"2023","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.coph.2025.102548_bib8","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12964-024-01511-2","article-title":"Deciphering the dynamics of methicillin-resistant Staphylococcus aureus biofilm formation: from molecular signaling to nanotherapeutic advances","volume":"22","author":"Aboelnaga","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.coph.2025.102548_bib9","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3390\/pathogens10080970","article-title":"Biofilm Formation of multidrug-resistant MRSA strains isolated from different types of human infections","volume":"10","author":"Silva","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.coph.2025.102548_sref10","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1021\/acsabm.3c00731","article-title":"Advances in transdermal delivery of antimicrobial peptides for wound management: biomaterial-based approaches and future perspectives","volume":"7","author":"Firdous","year":"2024","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.coph.2025.102548_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3390\/antibiotics12010184","article-title":"Antimicrobial peptides against bacterial pathogens: innovative delivery nanosystems for pharmaceutical applications","volume":"12","author":"Imperlini","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.coph.2025.102548_bib12","doi-asserted-by":"crossref","first-page":"840","DOI":"10.3390\/pharmaceutics12090840","article-title":"An update on antimicrobial peptides (AMPs) and their delivery strategies for wound infections","volume":"12","author":"Patrulea","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.coph.2025.102548_bib13","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1128\/AAC.02434-15","article-title":"Combination effects of antimicrobial peptides","volume":"60","author":"Yu","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.coph.2025.102548_bib14","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/antibiotics9010024","article-title":"Development and challenges of antimicrobial peptides for therapeutic applications","volume":"9","author":"Chen","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.coph.2025.102548_bib15","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1080\/07388551.2020.1796576","article-title":"Antimicrobial peptides as therapeutic agents: opportunities and challenges","volume":"40","author":"Mahlapuu","year":"2020","journal-title":"Crit Rev Biotechnol"},{"key":"10.1016\/j.coph.2025.102548_bib16","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.actbio.2019.12.025","article-title":"Topical antimicrobial peptide formulations for wound healing: current developments and future prospects","volume":"103","author":"Thapa","year":"2020","journal-title":"Acta Biomater"},{"key":"10.1016\/j.coph.2025.102548_bib17","first-page":"375","article-title":"Genetic characterization of methicillin-resistant Staphylococcus aureus isolates from human bloodstream infections: detection of MLSB resistance","volume":"9","author":"Silva","year":"2020","journal-title":"Antibiot Basel Switz"},{"key":"10.1016\/j.coph.2025.102548_bib18","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.2147\/IDR.S272733","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA): one health perspective approach to the bacterium epidemiology, virulence factors, antibiotic-resistance, and zoonotic impact","volume":"13","author":"Algammal","year":"2020","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.coph.2025.102548_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrmicro2200","article-title":"Waves of resistance: Staphylococcus aureus in the antibiotic era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coph.2025.102548_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.33","article-title":"Methicillin-resistant Staphylococcus aureus","volume":"4","author":"Lee","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.coph.2025.102548_bib21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4161\/viru.2.5.17724","article-title":"Staphylococcus aureus biofilms: properties, regulation, and roles in human disease","volume":"2","author":"Archer","year":"2011","journal-title":"Virulence"},{"key":"10.1016\/j.coph.2025.102548_bib22","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.biochi.2010.02.023","article-title":"Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity","volume":"92","author":"Takahashi","year":"2010","journal-title":"Biochimie"},{"key":"10.1016\/j.coph.2025.102548_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.582779","article-title":"Antimicrobial peptides: classification, design, application and research progress in multiple fields","volume":"11","author":"Huan","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coph.2025.102548_bib24","first-page":"48","article-title":"Antimicrobial peptides: mechanism of action, activity and clinical potential","volume":"8","author":"Zhang","year":"2021","journal-title":"Mil Med Res"},{"key":"10.1016\/j.coph.2025.102548_bib25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tibtech.2011.05.001","article-title":"The expanding scope of antimicrobial peptide structures and their modes of action","volume":"29","author":"Nguyen","year":"2011","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.coph.2025.102548_bib26","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.ejps.2013.05.005","article-title":"Microneedles for intradermal and transdermal drug delivery","volume":"50","author":"Tuan-Mahmood","year":"2013","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.coph.2025.102548_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202002129","article-title":"Advances in antimicrobial microneedle patches for combating infections","volume":"32","author":"Jamaledin","year":"2020","journal-title":"Adv Mater"},{"key":"10.1016\/j.coph.2025.102548_sref28","doi-asserted-by":"crossref","first-page":"11775","DOI":"10.1021\/acsnano.0c04527","article-title":"Dissolvable microneedles coupled with nanofiber dressings eradicate biofilms via effectively delivering a database-designed antimicrobial peptide","volume":"14","author":"Su","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.coph.2025.102548_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202100135","article-title":"Simultaneous delivery of multiple antimicrobial agents by biphasic scaffolds for effective treatment of wound biofilms","volume":"10","author":"Su","year":"2021","journal-title":"Adv Healthcare Mater"},{"key":"10.1016\/j.coph.2025.102548_sref30","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2023.02.030","article-title":"Triggered release of antimicrobial peptide from microneedle patches for treatment of wound biofilms","volume":"356","author":"Su","year":"2023","journal-title":"J Contr Release"},{"key":"10.1016\/j.coph.2025.102548_sref31","article-title":"\u201cOn-demand\u201d nanosystem-integrated microneedles for amplified triple therapy against recalcitrant bacteria and biofilm growth","volume":"29","author":"Wen","year":"2024","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.coph.2025.102548_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.148938","article-title":"Photothermal microneedle patch loaded with antimicrobial peptide\/MnO2 hybrid nanoparticles for chronic wound healing","volume":"482","author":"Wang","year":"2024","journal-title":"Chem Eng J"},{"key":"10.1016\/j.coph.2025.102548_bib33","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1021\/acs.molpharmaceut.2c00918","article-title":"Peptide stability is important but not a general requirement for antimicrobial and antibiofilm activity in vitro and in vivo","volume":"20","author":"Decker","year":"2023","journal-title":"Mol Pharm"},{"key":"10.1016\/j.coph.2025.102548_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fpubh.2014.00217","article-title":"Vancomycin revisited - 60 years later","volume":"2","author":"Rubinstein","year":"2014","journal-title":"Front Public Health"},{"key":"10.1016\/j.coph.2025.102548_bib35","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","article-title":"Antibiotic resistance\u2014the need for global solutions","volume":"13","author":"Laxminarayan","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coph.2025.102548_bib36","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jgar.2020.02.001","article-title":"Ceftaroline versus vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in an experimental MRSA meningitis model","volume":"22","author":"Mermer","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.coph.2025.102548_bib37","article-title":"Biomedical applications of polymeric microneedles for transdermal therapeutic delivery and diagnosis: current status and future perspectives","volume":"3","author":"Liu","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.coph.2025.102548_bib38","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.coph.2025.102548_bib39","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.3109\/10717544.2014.986309","article-title":"Microneedles for drug delivery: trends and progress","volume":"23","author":"Cheung","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.coph.2025.102548_bib40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2019.10.022","article-title":"Polymeric microneedles for controlled transdermal drug delivery","volume":"315","author":"Singh","year":"2019","journal-title":"J Contr Release"},{"key":"10.1016\/j.coph.2025.102548_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/admt.202001307","article-title":"Vancomycin-loaded microneedle arrays against methicillin-resistant Staphylococcus aureus skin infections","volume":"6","author":"Ziesmer","year":"2021","journal-title":"Adv Mater Technol"},{"key":"10.1016\/j.coph.2025.102548_bib42","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1021\/acs.molpharmaceut.0c00431","article-title":"Development, evaluation, and pharmacokinetic assessment of polymeric microarray patches for transdermal delivery of vancomycin hydrochloride","volume":"17","author":"Ramadon","year":"2020","journal-title":"Mol Pharm"},{"key":"10.1016\/j.coph.2025.102548_sref43","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3390\/jfb15110316","article-title":"Sodium alginate microneedles loaded with vancomycin for skin infections","volume":"15","author":"Abu Ershaid","year":"2024","journal-title":"J Funct Biomater"},{"key":"10.1016\/j.coph.2025.102548_sref44","article-title":"Hybrid microneedle arrays for antibiotic and near-IR photothermal synergistic antimicrobial effect against Methicillin-Resistant Staphylococcus aureus","volume":"462","author":"Ziesmer","year":"2023","journal-title":"Chem Eng J Lausanne Switz 1996"},{"key":"10.1016\/j.coph.2025.102548_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.691532","article-title":"Antimicrobial peptides and proteins: from nature's reservoir to the laboratory and beyond","volume":"9","author":"Sarkar","year":"2021","journal-title":"Front Chem"},{"key":"10.1016\/j.coph.2025.102548_bib46","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/molecules23020414","article-title":"Antibacterial peptides in dermatology\u2013strategies for evaluation of allergic potential","volume":"23","author":"Deptu\u0142a","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.coph.2025.102548_bib47","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2217\/fmb.11.27","article-title":"Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development","volume":"6","author":"Eckert","year":"2011","journal-title":"Future Microbiol"},{"key":"10.1016\/j.coph.2025.102548_bib48","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.drudis.2019.08.004","article-title":"Superbugs but no drugs: steps in averting a post-antibiotic era","volume":"24","author":"Hamad","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.coph.2025.102548_bib49","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2014.0086","article-title":"Time for a change: addressing R&D and commercialization challenges for antibacterials","volume":"370","author":"Payne","year":"2015","journal-title":"Philos Trans R Soc B Biol Sci."},{"key":"10.1016\/j.coph.2025.102548_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau5480","article-title":"Antimicrobial peptides: application informed by evolution","volume":"368","author":"Lazzaro","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coph.2025.102548_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125130","article-title":"Enhancing transdermal delivery of chrysomycin A for the treatment of cutaneous melanoma and MRSA infections using Skin-Penetrating Peptide-Functionalized deformable liposomes","volume":"670","author":"Cai","year":"2025","journal-title":"Int J Pharm"},{"key":"10.1016\/j.coph.2025.102548_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117518","article-title":"Synthesis and anti-MRSA activity of quaternized small molecule antimicrobial peptide mimics based on norharmane","volume":"290","author":"Dan","year":"2025","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.coph.2025.102548_bib53","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12967-025-06321-9","article-title":"Antimicrobial peptide biological activity, delivery systems and clinical translation status and challenges","volume":"23","author":"Zheng","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.coph.2025.102548_bib54","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jare.2024.01.023","article-title":"Specifically targeted antimicrobial peptides synergize with bacterial-entrapping peptide against systemic MRSA infections","volume":"67","author":"Xu","year":"2025","journal-title":"J Adv Res"},{"key":"10.1016\/j.coph.2025.102548_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/marc.202401046","article-title":"Advances in antimicrobial peptide-based biomaterials for combating multidrug-resistant bacterial infections","author":"Yuan","year":"2025","journal-title":"Macromol Rapid Commun"},{"key":"10.1016\/j.coph.2025.102548_bib56","doi-asserted-by":"crossref","first-page":"10462","DOI":"10.1039\/D5NR00953G","article-title":"Antimicrobial peptides and their application to combat implant-associated infections\u2013opportunities and challenges","volume":"17","author":"Khanda","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.coph.2025.102548_bib57","first-page":"11","article-title":"Epidermicin NI01, a first-in-class peptide antibiotic candidate, has potent efficacy in a robust MRSA wound infection model and low allergic reaction liabilities","author":"Upton","year":"2025","journal-title":"ESCMID Global"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148922500044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148922500044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:25:54Z","timestamp":1774517154000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147148922500044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":57,"alternative-id":["S147148922500044X"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2025.102548","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transdermal delivery of antibacterial peptides in the management of methicillin-resistant Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2025.102548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102548"}}